Cipla Limited

CIPLA.NS · Moat type: REGULIERUNG

MoatScore

4/10

Fair Value

734 INR (≈ 7.63 USD)

Margin of Safety

-96.0 %

Rating

BEOBACHTEN

Cipla Limited is an Indian pharmaceutical company that develops, manufactures, and distributes generic and branded medications in the therapeutic focus areas of respiratory, cardiology, oncology, and anti-infectives to over 80 countries, including India, the USA, South Africa, and Europe.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.